[시장보고서]세계의 창상 데브리드먼트 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 방법별, 창상 유형별, 최종 용도별, 구입 방법별, 지역별, 부문 예측(2025-2030년)

세계의 창상 데브리드먼트 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 방법별, 창상 유형별, 최종 용도별, 구입 방법별, 지역별, 부문 예측(2025-2030년)

Wound Debridement Market Size, Share & Trends Analysis Report By Product (Gels, Ointments & Creams, Wound Irrigation Solution), By Method, By Wound Type, By End-use, By Mode Of Purchase, By Region, And Segment Forecasts, 2025 - 2030

상품코드 : 1750863

리서치사 : Grand View Research, Inc.

발행일 : 2025년 05월

페이지 정보 : 영문 90 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,641,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,094,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 12,998,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

세계의 창상 데브리드먼트 시장의 성장과 동향

Grand View Research, Inc의 최신 보고서에 따르면 세계의 창상 데브리드먼트 시장 규모는 2030년까지 71억 7,000만 달러에 달할 것으로 예측되며, 2025-2030년까지의 CAGR은 6.2%로 확대될 전망입니다.

창상 데브리드먼트 제품은 상처 치유를 억제하는 미생물과 독소의 제거와 부하의 경감에 도움이 됩니다. 국제 당뇨병 연합에 따르면 당뇨병의 발병률은 2040년까지 6억 4,200만 명에 달할 것으로 예측됩니다. 미국에서는 당뇨병 환자 증가에 따라, 창상 데브리드먼트 수요가 증가하고 있습니다. 약 19만 5,000명이 사망하고 있습니다. 이에 더해 창상 데브리드먼트의 중요성에 대한 의식의 고조가 향후 수년간 시장에 플러스의 영향을 줄 것으로 예측됩니다.

첨단 창상 데브리드먼트 제품의 개발은 시장 성장을 뒷받침하고 있습니다. 증명되었습니다. 케라틴 매트릭스는 상처에 흡수되기 때문에 드레싱 재료의 교체가 필요하지 않습니다.

창상 데브리드먼트 시장 보고서 하이라이트

제품별로는 의료용 가제가 2024년에 22.84%의 최대 매출 점유율로 시장을 리드하고 있습니다.
방법별로는 수술적 창상 데브리드먼트이 2024년에 최대 점유율을 차지했습니다.
상처 유형별로는 당뇨병성 발궤양이 2024년에 최대 점유율을 차지했습니다. 이 우위성은 발의 변형이나 외상을 수반하는 당뇨병 환자 증가에 기인하고 있습니다.
구매방법별로는 시판약이 예측기간 중 가장 빠른 CAGR을 나타낼 것으로 예측되고 있습니다.
아시아태평양은 예측 기간 동안 가장 급성장할 것으로 예측됩니다.

시장 계통 전망
- 보조 시장 전망
시장 역학
- 시장 성장 촉진요인 분석
- 시장 성장 억제요인 분석
- 시장 기회 분석
- 시장 과제 분석
창상 데브리드먼트 시장 분석 도구
- 업계 분석 - Porter's Five Forces 분석
- PESTEL 분석
- COVID-19의 영향 분석

제4장 창상 데브리드먼트 시장 : 제품별, 추정 및 동향 분석

부문 대시보드
창상 데브리드먼트 시장 : 제품 변동 분석과 시장 점유율, 2024년 및 2030년
겔
상처 세정액
연고 및 크림
외과용 기기
의료용 거즈
초음파 장치
기타

제5장 창상 데브리드먼트 시장 : 방법별, 추정 및 동향 분석

부문 대시보드
창상 데브리드먼트 시장 : 방법 변동 분석과 시장 점유율, 2024 년과 2030년
자기분해
효소
외과적
기계적
기타

제6장 창상 데브리드먼트 시장 : 창상 유형별, 추정 및 동향 분석

부문 대시보드
상처 데브리드먼트 시장 : 상처 유형 변동 분석과 시장 점유율, 2024년 및 2030년
욕창
- 스테이지 1
- 스테이지 2
- 스테이지 3
- 스테이지 4
- 심부 조직 손상
당뇨병성 발궤양
정맥성 다리 궤양
화상
- 2도(부분층)
- 3도(전층) 열상
기타

제7장 창상 데브리드먼트 시장 : 최종 용도별, 추정 및 동향 분석

부문 대시보드
상처 데브리드먼트 시장 : 최종 용도 변동 분석과 시장 점유율, 2024년 및 2030년
병원(입원)
병원(외래)
복잡한 상처 클리닉
하지 궤양 클리닉
당뇨병 발병 클리닉
워크인 클리닉
발병 클리닉
일반 개업의(GP) 외과
노인 홈
홈헬스
재택 입원(HAD)

제8장 창상 데브리드먼트 시장 : 구입 방법별, 추정 및 동향 분석

부문 대시보드
상처 데브리드먼트 시장 : 구매 방법 변동 분석과 시장 점유율, 2024년 및 2030년
처방전
시판약
기타

제9장 창상 데브리드먼트 시장 : 지역별, 추정 및 동향 분석

지역 전망
상처 데브리드먼트 시장 :지역 변동 분석과 시장 점유율, 2024년 및 2030년
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 일본
- 중국
- 인도
- 한국
- 호주
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카
- 사우디아라비아
- 아랍에미리트(UAE)
- 쿠웨이트

제10장 경쟁 구도

시장 진출기업의 분류
주요 기업 프로파일
- Coloplast Corp
- Medline Industries
- Smith & Nephew
- ConvaTec Group PLC
- Integra LifeSciences
- B. Braun SE
- Molnlycke Health Care AB
- Lohmann & Rauscher
- 3M
- Schulke & Mayr GmbH
- Cardinal Health
- SERAG-WIESSNER GmbH & Co. KG
- Lotus Surgicals Pvt Ltd
- ActiMaris
- BAIHE MEDICAL EUROPE
- URGO MEDICAL
- BD
- Bravida Medical
- Advanced Medical Solutions Limited
- Advancis Medical
- curea medical GmbH
- DEBX MEDICAL
- Dr. Ausbuttel & Co. GmbH(Draco)
히트맵 분석/기업시장 포지셔닝 분석
2024년 기업의 시장 점유율 예측 분석
기타 주요 시장 기업 목록

>JHS

영문 목차

영문목차

Wound Debridement Market Growth & Trends:

The global wound debridement market size is anticipated to reach USD 7.17 billion by 2030, expected to expand at a CAGR of 6.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising cases of injuries that require cleaning and removal of necrotic tissue are leading to increasing demand for wound debridement products.

Wound debridement products help in eliminating or reducing the load of microbes and toxins that inhibit wound healing. Increasing incidence of diabetes and obesity escalates the level of chronic wounds such as diabetic foot ulcers. As per the International Diabetes Federation, the incidence of diabetes is expected to reach 642.0 million by 2040. Prevention of wound infection is one of the major concerns for diabetic patients, making wound debridement vital. With the increase in the number of diabetics in the U.S., demand for wound debridement is on a rise. Burns are the most common wounds and account for around 195,000 deaths annually. This, in addition to rising awareness regarding the importance of wound debridement, is expected to positively affect the market in the coming years.

Development of advanced wound debridement products is also boosting the market growth. For instance, the launch of keratin-based wound care products that are used along with dressings has proven to be extremely helpful in wound re-epithelialization. The keratin matrix is absorbed in the wound and eliminates the need for a dressing change. Such developments are anticipated to create growth opportunities for market players in the coming years.

Wound Debridement Market Report Highlights:

The medical gauze segment led the market with the largest revenue share of 22.84% in 2024. Medical gauzes help in maintaining moisture around the wound, which allows rapid healing.
The surgical wound debridement segment accounted for the largest revenue share in 2024. It is the fastest way of wound debridement procedure to achieve a clean wound bed, thereby contributing to the segment growth.
By wound type, diabetic foot ulcers segment accounted for the largest market revenue share in 2024. This dominance can be attributed to the increasing number of diabetic patients, coupled with several foot deformities and trauma.
The over-the-counter segment is projected to witness at the fastest CAGR over the forecast period. Several OTC wound debridement products are available in the market for the treatment of various wounds, such as cuts, abrasions, scrapes, and scratches.
Asia Pacific is anticipated to witness fastest growth over the forecast period. Progressive economy, reforms to improve infrastructure, high unmet needs of a massive population, and availability of skilled labor is expected to drive the market in this region

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Research Methodology
1.3. Information Procurement
1.4. Purchased database.
1.5. GVR's internal database
1.6. Secondary sources
1.7. Third Party Perspective
1.8. Primary research
1.9. Details of primary research
1.10. Information or Data Analysis
1.11. Data analysis models
1.12. Market Formulation & Validation
1.13. Model Details
1.14. Commodity flow analysis (Model 1)
1.15. Approach 1: Commodity flow approach
1.16. Volume price analysis (Model 2)
1.17. Approach 2: Volume price analysis
1.18. List of Secondary Sources
1.19. List of Primary Sources
1.20. List of Abbreviations

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Wound Debridement Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Ancillary Market Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Rising prevalence of chronic diseases
  - 3.2.1.2. Increasing number of accidents
  - 3.2.1.3. Increasing number of ambulatory surgical centers (ASCs)
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. Rising treatment cost
- 3.2.3. Market Opportunities Analysis
  - 3.2.3.1. Introduction of technologically advanced products
- 3.2.4. Market Challenges Analysis
  - 3.2.4.1. Stringent manufacturing policies
3.3. Wound Debridement Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Bargaining power of suppliers
  - 3.3.1.2. Bargaining power of buyers
  - 3.3.1.3. Threat of substitutes
  - 3.3.1.4. Threat of new entrants
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political & Legal Landscape
  - 3.3.2.2. Economic and Social Landscape
  - 3.3.2.3. Technological landscape
- 3.3.3. COVID-19 Impact Analysis
  - 3.3.3.1. Disrupted Breast Pump
  - 3.3.3.2. Obstacles in Breast Pump

Chapter 4. Wound Debridement Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Wound Debridement Market: Product Movement Analysis & Market Share, 2024 & 2030
4.3. Gels
- 4.3.1. Gels Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Wound Irrigation Solution
- 4.4.1. Wound Irrigation Solution Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Ointments & Creams
- 4.5.1. Ointments & Creams Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Surgical Devices
- 4.6.1. Surgical Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Medical Gauzes
- 4.7.1. Medical Gauzes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Ultrasonic Devices
- 4.8.1. Ultrasonic Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9. Others
- 4.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Wound Debridement Market: Method Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Wound Debridement Market: Method Movement Analysis & Market Share, 2024 & 2030
5.3. Autolytic
- 5.3.1. Autolytic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Enzymatic
- 5.4.1. Enzymatic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Surgical
- 5.5.1. Surgical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Mechanical
- 5.6.1. Mechanical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Others
- 5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Wound Debridement Market: Wound Type Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Wound Debridement Market: Wound Type Movement Analysis & Market Share, 2024 & 2030
6.3. Pressure Ulcers
- 6.3.1. Pressure Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.2. Stage 1
  - 6.3.2.1. Stage 1 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.3. Stage 2
  - 6.3.3.1. Stage 12 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.4. Stage 3
  - 6.3.4.1. Stage 3 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.5. Stage 4
  - 6.3.5.1. Stage 4 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.6. Deep Tissue Injury
  - 6.3.6.1. Deep Tissue Injury Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Diabetic Foot Ulcers
- 6.4.1. Diabetic Foot Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Venous Leg Ulcers
- 6.5.1. Venous Leg Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Burn Wounds
- 6.6.1. Burn Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.2. Second-degree (partial-thickness)
  - 6.6.2.1. Second-degree (partial-thickness) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.3. Third-degree (full-thickness) Burns
  - 6.6.3.1. Third-degree (full-thickness) Burns Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Others
- 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Wound Debridement Market: End Use Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Wound Debridement Market: End Use Movement Analysis & Market Share, 2024 & 2030
7.3. Hospital (Inpatient)
- 7.3.1. Hospital (Inpatient) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Hospital (Outpatient)
- 7.4.1. Hospital (Outpatient) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Complex Wound Clinic
- 7.5.1. Complex Wound Clinic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Leg Ulcer Clinic
- 7.6.1. Leg Ulcer Clinic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Diabetic Foot Clinic
- 7.7.1. Diabetic Foot Clinic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. Walking-in Clinic
- 7.8.1. Walking-in Clinic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9. Podiatry Clinic
- 7.9.1. Podiatry Clinic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.10. General Practitioners (GP) Surgery
- 7.10.1. General Practitioners (GP) Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.11. Nursing Home
- 7.11.1. Nursing Home Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.12. Home Health
- 7.12.1. Home Health Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.13. Hospitalization at Home (HAD)
- 7.13.1. Hospitalization at Home (HAD) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Wound Debridement Market: Mode of Purchase Estimates & Trend Analysis

8.1. Segment Dashboard
8.2. Wound Debridement Market: Mode of Purchase Movement Analysis & Market Share, 2024 & 2030
8.3. Prescription
- 8.3.1. Prescription Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Over The Counter
- 8.4.1. Over The Counter Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Others
- 8.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Wound Debridement Market: Regional Estimates & Trend Analysis

9.1. Regional Outlook
9.2. Wound Debridement Market: Regional Movement Analysis & Market Share, 2024 & 2030
9.3. North America
- 9.3.1. North America Wound Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.2. U.S.
  - 9.3.2.1. Key Country Dynamics
  - 9.3.2.2. Competitive Scenario
  - 9.3.2.3. Regulatory Scenario
  - 9.3.2.4. Reimbursement Scenario
  - 9.3.2.5. U.S. Wound Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.3. Canada
  - 9.3.3.1. Key Country Dynamics
  - 9.3.3.2. Competitive Scenario
  - 9.3.3.3. Regulatory Scenario
  - 9.3.3.4. Reimbursement Scenario
  - 9.3.3.5. Canada Wound Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.4. Mexico
  - 9.3.4.1. Key Country Dynamics
  - 9.3.4.2. Competitive Scenario
  - 9.3.4.3. Regulatory Scenario
  - 9.3.4.4. Reimbursement Scenario
  - 9.3.4.5. Mexico Wound Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4. Europe
- 9.4.1. Europe Wound Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.2. UK
  - 9.4.2.1. Key Country Dynamics
  - 9.4.2.2. Competitive Scenario
  - 9.4.2.3. Regulatory Scenario
  - 9.4.2.4. Reimbursement Scenario
  - 9.4.2.5. UK Wound Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.3. Germany
  - 9.4.3.1. Key Country Dynamics
  - 9.4.3.2. Competitive Scenario
  - 9.4.3.3. Regulatory Scenario
  - 9.4.3.4. Reimbursement Scenario
  - 9.4.3.5. Germany Wound Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.4. France
  - 9.4.4.1. Key Country Dynamics
  - 9.4.4.2. Competitive Scenario
  - 9.4.4.3. Regulatory Scenario
  - 9.4.4.4. Reimbursement Scenario
  - 9.4.4.5. France Wound Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.5. Italy
  - 9.4.5.1. Key Country Dynamics
  - 9.4.5.2. Competitive Scenario
  - 9.4.5.3. Regulatory Scenario
  - 9.4.5.4. Reimbursement Scenario
  - 9.4.5.5. Italy Wound Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.6. Spain
  - 9.4.6.1. Key Country Dynamics
  - 9.4.6.2. Competitive Scenario
  - 9.4.6.3. Regulatory Scenario
  - 9.4.6.4. Reimbursement Scenario
  - 9.4.6.5. Spain Wound Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.7. Denmark
  - 9.4.7.1. Key Country Dynamics
  - 9.4.7.2. Competitive Scenario
  - 9.4.7.3. Regulatory Scenario
  - 9.4.7.4. Reimbursement Scenario
  - 9.4.7.5. Denmark Wound Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.8. Sweden
  - 9.4.8.1. Key Country Dynamics
  - 9.4.8.2. Competitive Scenario
  - 9.4.8.3. Regulatory Scenario
  - 9.4.8.4. Reimbursement Scenario
  - 9.4.8.5. Sweden Wound Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.9. Norway
  - 9.4.9.1. Key Country Dynamics
  - 9.4.9.2. Competitive Scenario
  - 9.4.9.3. Regulatory Scenario
  - 9.4.9.4. Reimbursement Scenario
  - 9.4.9.5. Norway Wound Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5. Asia Pacific
- 9.5.1. Asia Pacific Wound Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.5.2. Japan
  - 9.5.2.1. Key Country Dynamics
  - 9.5.2.2. Competitive Scenario
  - 9.5.2.3. Regulatory Scenario
  - 9.5.2.4. Reimbursement Scenario
  - 9.5.2.5. Japan Wound Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.5.3. China
  - 9.5.3.1. Key Country Dynamics
  - 9.5.3.2. Competitive Scenario
  - 9.5.3.3. Regulatory Scenario
  - 9.5.3.4. Reimbursement Scenario
  - 9.5.3.5. China Wound Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.5.4. India
  - 9.5.4.1. Key Country Dynamics
  - 9.5.4.2. Competitive Scenario
  - 9.5.4.3. Regulatory Scenario
  - 9.5.4.4. Reimbursement Scenario
  - 9.5.4.5. India Wound Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.5.5. South Korea
  - 9.5.5.1. Key Country Dynamics
  - 9.5.5.2. Competitive Scenario
  - 9.5.5.3. Regulatory Scenario
  - 9.5.5.4. Reimbursement Scenario
  - 9.5.5.5. South Korea Wound Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.5.6. Australia
  - 9.5.6.1. Key Country Dynamics
  - 9.5.6.2. Competitive Scenario
  - 9.5.6.3. Regulatory Scenario
  - 9.5.6.4. Reimbursement Scenario
  - 9.5.6.5. Australia Wound Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.5.7. Thailand
  - 9.5.7.1. Key Country Dynamics
  - 9.5.7.2. Competitive Scenario
  - 9.5.7.3. Regulatory Scenario
  - 9.5.7.4. Reimbursement Scenario
  - 9.5.7.5. Thailand Wound Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6. Latin America
- 9.6.1. Latin America Wound Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.6.2. Brazil
  - 9.6.2.1. Key Country Dynamics
  - 9.6.2.2. Competitive Scenario
  - 9.6.2.3. Regulatory Scenario
  - 9.6.2.4. Reimbursement Scenario
  - 9.6.2.5. Brazil Wound Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.6.3. Argentina
  - 9.6.3.1. Key Country Dynamics
  - 9.6.3.2. Competitive Scenario
  - 9.6.3.3. Regulatory Scenario
  - 9.6.3.4. Reimbursement Scenario
  - 9.6.3.5. Argentina Wound Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.7. Middle East & Africa
- 9.7.1. Middle East & Africa Wound Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.7.2. South Africa
  - 9.7.2.1. Key Country Dynamics
  - 9.7.2.2. Competitive Scenario
  - 9.7.2.3. Regulatory Scenario
  - 9.7.2.4. Reimbursement Scenario
  - 9.7.2.5. South Africa Wound Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.7.3. Saudi Arabia
  - 9.7.3.1. Key Country Dynamics
  - 9.7.3.2. Competitive Scenario
  - 9.7.3.3. Regulatory Scenario
  - 9.7.3.4. Reimbursement Scenario
  - 9.7.3.5. Saudi Arabia Wound Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.7.4. UAE
  - 9.7.4.1. Key Country Dynamics
  - 9.7.4.2. Competitive Scenario
  - 9.7.4.3. Regulatory Scenario
  - 9.7.4.4. Reimbursement Scenario
  - 9.7.4.5. UAE Wound Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.7.5. Kuwait
  - 9.7.5.1. Key Country Dynamics
  - 9.7.5.2. Competitive Scenario
  - 9.7.5.3. Regulatory Scenario
  - 9.7.5.4. Reimbursement Scenario
  - 9.7.5.5. Kuwait Wound Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

10.1. Market Participant Categorization
10.2. Key Company Profiles
- 10.2.1. Coloplast Corp
  - 10.2.1.1. Company Overview
  - 10.2.1.2. Financial Performance
  - 10.2.1.3. Product Benchmarking
  - 10.2.1.4. Strategic Initiatives
- 10.2.2. Medline Industries
  - 10.2.2.1. Company Overview
  - 10.2.2.2. Financial Performance
  - 10.2.2.3. Product Benchmarking
  - 10.2.2.4. Strategic Initiatives
- 10.2.3. Smith & Nephew
  - 10.2.3.1. Company Overview
  - 10.2.3.2. Financial Performance
  - 10.2.3.3. Product Benchmarking
  - 10.2.3.4. Strategic Initiatives
- 10.2.4. ConvaTec Group PLC
  - 10.2.4.1. Company Overview
  - 10.2.4.2. Financial Performance
  - 10.2.4.3. Product Benchmarking
  - 10.2.4.4. Strategic Initiatives
- 10.2.5. Integra LifeSciences
  - 10.2.5.1. Company Overview
  - 10.2.5.2. Financial Performance
  - 10.2.5.3. Product Benchmarking
  - 10.2.5.4. Strategic Initiatives
- 10.2.6. B. Braun SE
  - 10.2.6.1. Company Overview
  - 10.2.6.2. Financial Performance
  - 10.2.6.3. Product Benchmarking
  - 10.2.6.4. Strategic Initiatives
- 10.2.7. Molnlycke Health Care AB
  - 10.2.7.1. Company Overview
  - 10.2.7.2. Financial Performance
  - 10.2.7.3. Product Benchmarking
  - 10.2.7.4. Strategic Initiatives
- 10.2.8. Lohmann & Rauscher
  - 10.2.8.1. Company Overview
  - 10.2.8.2. Financial Performance
  - 10.2.8.3. Product Benchmarking
  - 10.2.8.4. Strategic Initiatives
- 10.2.9. 3M
  - 10.2.9.1. Company Overview
  - 10.2.9.2. Financial Performance
  - 10.2.9.3. Product Benchmarking
  - 10.2.9.4. Strategic Initiatives
- 10.2.10. Schulke & Mayr GmbH
  - 10.2.10.1. Company Overview
  - 10.2.10.2. Financial Performance
  - 10.2.10.3. Product Benchmarking
  - 10.2.10.4. Strategic Initiatives
- 10.2.11. Cardinal Health
  - 10.2.11.1. Company Overview
  - 10.2.11.2. Financial Performance
  - 10.2.11.3. Product Benchmarking
  - 10.2.11.4. Strategic Initiatives
- 10.2.12. SERAG-WIESSNER GmbH & Co. KG
  - 10.2.12.1. Company Overview
  - 10.2.12.2. Financial Performance
  - 10.2.12.3. Product Benchmarking
  - 10.2.12.4. Strategic Initiatives
- 10.2.13. Lotus Surgicals Pvt Ltd
  - 10.2.13.1. Company Overview
  - 10.2.13.2. Financial Performance
  - 10.2.13.3. Product Benchmarking
  - 10.2.13.4. Strategic Initiatives
- 10.2.14. ActiMaris
  - 10.2.14.1. Company Overview
  - 10.2.14.2. Financial Performance
  - 10.2.14.3. Product Benchmarking
  - 10.2.14.4. Strategic Initiatives
- 10.2.15. BAIHE MEDICAL EUROPE
  - 10.2.15.1. Company Overview
  - 10.2.15.2. Financial Performance
  - 10.2.15.3. Product Benchmarking
  - 10.2.15.4. Strategic Initiatives
- 10.2.16. URGO MEDICAL
  - 10.2.16.1. Company Overview
  - 10.2.16.2. Financial Performance
  - 10.2.16.3. Product Benchmarking
  - 10.2.16.4. Strategic Initiatives
- 10.2.17. BD
  - 10.2.17.1. Company Overview
  - 10.2.17.2. Financial Performance
  - 10.2.17.3. Product Benchmarking
  - 10.2.17.4. Strategic Initiatives
- 10.2.18. Bravida Medical
  - 10.2.18.1. Company Overview
  - 10.2.18.2. Financial Performance
  - 10.2.18.3. Product Benchmarking
  - 10.2.18.4. Strategic Initiatives
- 10.2.19. Advanced Medical Solutions Limited
  - 10.2.19.1. Company Overview
  - 10.2.19.2. Financial Performance
  - 10.2.19.3. Product Benchmarking
  - 10.2.19.4. Strategic Initiatives
- 10.2.20. Advancis Medical
  - 10.2.20.1. Company Overview
  - 10.2.20.2. Financial Performance
  - 10.2.20.3. Product Benchmarking
  - 10.2.20.4. Strategic Initiatives
- 10.2.21. curea medical GmbH
  - 10.2.21.1. Company Overview
  - 10.2.21.2. Financial Performance
  - 10.2.21.3. Product Benchmarking
  - 10.2.21.4. Strategic Initiatives
- 10.2.22. DEBX MEDICAL
  - 10.2.22.1. Company Overview
  - 10.2.22.2. Financial Performance
  - 10.2.22.3. Product Benchmarking
  - 10.2.22.4. Strategic Initiatives
- 10.2.23. Dr. Ausbuttel & Co. GmbH (Draco)
  - 10.2.23.1. Company Overview
  - 10.2.23.2. Financial Performance
  - 10.2.23.3. Product Benchmarking
  - 10.2.23.4. Strategic Initiatives
10.3. Heat Map Analysis/ Company Market Position Analysis
10.4. Estimated Company Market Share Analysis, 2024
10.5. List of Other Key Market Players